Milla Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MILLA PHARMS, and what generic and branded alternatives to MILLA PHARMS drugs are available?
MILLA PHARMS has four approved drugs.
Summary for Milla Pharms
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Milla Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Milla Pharms | PYRIDOSTIGMINE BROMIDE | pyridostigmine bromide | SYRUP;ORAL | 212405-001 | Apr 19, 2022 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Milla Pharms | SODIUM ACETATE | sodium acetate | SOLUTION;INTRAVENOUS | 214805-002 | Aug 25, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Milla Pharms | SODIUM ACETATE | sodium acetate | SOLUTION;INTRAVENOUS | 214805-004 | Jan 22, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Milla Pharms | SODIUM ACETATE | sodium acetate | SOLUTION;INTRAVENOUS | 214805-003 | May 4, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Milla Pharms | DEXMEDETOMIDINE HYDROCHLORIDE | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 217308-002 | Jun 7, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Milla Pharms | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 209642-001 | Nov 8, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
